Can Japan’s Richest Person Save Cell Therapy’s Future?

Yanai Donates $30m To New iPSC Production Facility

 
• By Lisa Takagi
  
Japan iPSC lab
New Japan production facility aims to lower cost of induced pluripotent stem cell therapies. (Shutterstock/AI-generated)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Business